Cyclosporine 0.05% Ophthalmic Emulsion for Dry Eye in Korea: A Prospective, Multicenter, Open-Label, Surveillance Study
Yong-Soo Byun, Chang Rae Rho, Kyungjin Cho, Jin A Choi, Kyung Sun Na, Choun-Ki Joo
Korean J Ophthalmol. 2011;25(6):369-374.   Published online 2011 Nov 22     DOI: https://doi.org/10.3341/kjo.2011.25.6.369
Citations to this article as recorded by Crossref logo
Topical cyclosporine a (0.05%) treatment in dry eye patients: a comparison study of Sjogren’s syndrome versus non-Sjogren’s syndrome
Mehmet Ozgur Cubuk, Ahmet Yucel Ucgul, Armagan Ozgur, Kemal Ozulken, Erdem Yuksel
International Ophthalmology.2021; 41(4): 1479.     CrossRef
Contributing Factors Affecting Ocular Discomfort on Instillation and Compliance of 0.1% Cyclosporine A Cationic Nanoemulsion
Won Jun Lee, Yeoun Sook Chun, Kyoung Woo Kim
Journal of the Korean Ophthalmological Society.2021; 62(4): 429.     CrossRef
A Review of Management Strategies for Nociceptive and Neuropathic Ocular Surface Pain
Harrison Dermer, Daniella Lent-Schochet, Despoina Theotoka, Christian Paba, Abdullah A. Cheema, Ryan S. Kim, Anat Galor
Drugs.2020; 80(6): 547.     CrossRef

Treatment Satisfaction Among Patients Using Anti-Inflammatory Topical Medications for Dry Eye Disease

Darrell E White, Yang Zhao, Hemalatha Jayapalan, Pattabhi Machiraju, Ramu Periyasamy, Abayomi Ogundele
Clinical Ophthalmology.2020; Volume 14: 875.     CrossRef
Association of Killer Cell Immunoglobulin-like Receptor Genotypes and Haplotypes in Dry Eye Disease Patients Treated with Restasis and Systane
Gui-Fang Ren, Lin Zhu, Yun-Long Zhuang, Yun-Xia Liu, Jing Huang, Hui Wang, Qun Wang
Ocular Immunology and Inflammation.2020; : 1.     CrossRef

Improving Tolerance and Compliance with Topical Immunomodulators Using Micro-Emulsion Lipid Layer Artificial Tears

Alice T Epitropoulos, Anthony Therattil, Laura M Periman, Eric D Rosenberg
Clinical Ophthalmology.2020; Volume 14: 1921.     CrossRef
Evaluation of the Efficacy and Safety of A Novel 0.05% Cyclosporin A Topical Nanoemulsion in Primary Sjögren’s Syndrome Dry Eye
Min-Ji Kang, Youn-Hee Kim, Miyoung Chou, Jehyung Hwang, Eun-Jeong Cheon, Hyun-Jung Lee, So-Hyang Chung
Ocular Immunology and Inflammation.2020; 28(3): 370.     CrossRef
Cyclosporine Anionic and Cationic Ophthalmic Emulsions in Dry Eye Disease: A Literature Review
Louis Tong, Chi Chin Sun, Kyung Chul Yoon, Ruben Lim Bon Siong, Vilavun Puangsricharern, Christophe Baudouin
Ocular Immunology and Inflammation.2020; : 1.     CrossRef
Comparison of Treatment Effect and Tolerance of the Topical Application of Mizoribine and Cyclosporine A in a Mouse Dry Eye Model
Xiang Lin, Yang Wu, Liying Tang, Weijie Ouyang, Yiran Yang, Zhaolin Liu, Jieli Wu, Xiaoxiang Zheng, Caihong Huang, Yueping Zhou, Xiaobo Zhang, Yongxiong Chen, Wei Li, Jiaoyue Hu, Zuguo Liu
Translational Vision Science & Technology.2020; 9(13): 22.     CrossRef
Topical Cyclosporine (0.05%) for Management of Dry Eyes in Patients Undergoing Cataract Surgery-A Comparative Study
Sri Ganesh, Sheetal Brar, Sheetal N. Bagare
The Open Ophthalmology Journal.2019; 13(1): 34.     CrossRef
Current and emerging therapy of dry eye disease. Part A: pharmacological modalities
Nariman Nassiri, Yasaira Rodriguez Torres, Zachary Meyer, Michael A. Beyer, Gautham Vellaichamy, Amar S. Dhaliwal, Neil Chungfat, Frank S. Hwang
Expert Review of Ophthalmology.2017; 12(4): 269.     CrossRef
New Perspectives on Dry Eye Definition and Diagnosis: A Consensus Report by the Asia Dry Eye Society
Kazuo Tsubota, Norihiko Yokoi, Jun Shimazaki, Hitoshi Watanabe, Murat Dogru, Masakazu Yamada, Shigeru Kinoshita, Hyo-Myung Kim, Hung-Won Tchah, Joon Young Hyon, Kyung-Chul Yoon, Kyoung Yul Seo, Xuguang Sun, Wei Chen, Lingyi Liang, Mingwu Li, Zuguo Liu, Zu
The Ocular Surface.2017; 15(1): 65.     CrossRef
Comparisons for Evaluation of Efficacy and Safety of Cyclosporin A 0.05% Ophthalmic Emulsion Treatment Groups
Soonwon Yang, Yong-Soo Byun, Chang Rae Rho, Su Young Kim, Yang Kyung Cho, Eun Chul Kim, Sung Kun Chung, Choun-Ki Joo
Journal of the Korean Ophthalmological Society.2016; 57(12): 1849.     CrossRef
Therapeutic Strategies to Treat Dry Eye in an Aging Population
Nisreen S. Ezuddin, Karam A. Alawa, Anat Galor
Drugs & Aging.2015; 32(7): 505.     CrossRef
Cyclosporine ophthalmic emulsions for the treatment of dry eye: a review of the clinical evidence
Philip Ames, Anat Galor
Clinical Investigation.2015; 5(3): 267.     CrossRef
Safety and Efficacy of Cyclosporine in the Treatment of Chronic Dry Eye
Clyde Schultz
Ophthalmology and Eye Diseases.2014; 6: OED.S16067.     CrossRef
Short-term effects of topical cyclosporine A 0.05% (Restasis) in long-standing prosthetic eye wearers: a pilot study
J W Han, J S Yoon, S Y Jang
Eye.2014; 28(10): 1212.     CrossRef
Effect of Cyclosporin A on Tear Film and Corneal Aberration after Cataract Surgery
Jei Hun Jeon, Hong Seok Kim, Ji Won Jung, Sang Chul Yoon, Kyoung Yul Seo, Hyung Keun Lee, Eung Kweon Kim, Tae Im Kim
Journal of the Korean Ophthalmological Society.2014; 55(7): 978.     CrossRef
Effects of Cyclosporine 0.05% Ophthalmic Emulsion to Improve Reduction of Tear Production after Cataract Surgery
Ae Ri Yoo, Hyung Bin Hwang, Hyun Kyung Kim, Sung Kun Chung
Journal of the Korean Ophthalmological Society.2013; 54(7): 1013.     CrossRef